Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04845867

A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical Product

After thyroid surgery, 0.6 to 4% of patients develop postoperative bleeding. 90% of this postoperative bleeding occurs within the first 48 hours. Most of the time, the complications are rapidly progressing and require immediate attention. Up to 0.6% of patients with postoperative bleeding die. In a clinical study with postoperative pressure measurements it could be shown that postoperative bleeding without interruption leads to a continuous increase in pressure in the neck, as is observed when coughing and pressing. Systematic invasive pressure measurement in the thyroid compartment after surgery might detect a continuous increase in pressure which is often caused by a growing haematoma, indicating serious post-surgery bleeding at a much earlier time compared to state of the art diagnostic workflow. n routine clinical care, detection of serious haemorrhage depends on the patients alerting symptoms even if post-operative intermittent monitoring of vital parameters and wound conditions is performed according to current medical guidelines and local instructions. Device-based, continuous haemorrhage detection within 36 to 48 hours after surgery would allow to objectively measure an increase in cervical pressure before symptoms occur, i.e. early detection of risk leading to timely therapeutic actions. Thus, the risk of serious complications like hypoxic brain damage and death caused by post-operative haemorrhage is minimized. In addition, the intervention team would be able to fine-tune necessary actions during the rescue procedure based on objective pressure values, e.g. the decision to open cutaneous sutures immediately or later in the operation theatre, and therefore reduce additional perioperative morbidity and increase patients' safety.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years.
  • Indication for thyroid surgery (e.g. total thyroidectomy, subtotal resection, partial resection or lobectomy) in routine clinical care according to applicable medical guidelines using all adequate surgical approaches.
  • Signed informed consent

Exclusion criteria

  • Intended use of drains

Treatment and study plan

ISAR-M THYRO

Device

A diagnostic device for early detection of haemorrhage following thyroid surgery

Primary outcomes

  1. Sensitivity and specificity

    Time frame: within 48 hours following thyroid surgery

    detection of clinically relevant haemorrhage compared to the gold standard of detection in routine clinical care using 15 mmHg as cut-off

  2. Sensitivity and specificity

    Time frame: within 48 hours following thyroid surgery

    Sensitivity and specificity of detection of clinically relevant haemorrhage within 48 hours following thyroid surgery compared to the gold standard of routine clinical care detection in a three-level decision system using 10 and 20 mmHg as cut-offs

Secondary outcomes

  1. Specificity

    Time frame: within 48 hours following thyroid surgery

    Specificity as well as positive and negative predictive values of detection of clinically relevant haemorrhage within 48 hours following thyroid surgery compared to the gold standard of detection in routine clinical care using the two-level and the three-level decision system.following thyroid surgery compared to the gold standard of routine clinical care detection in routine clinical care using the two-level and three-level decision system

  2. Safety of the use of ISAR-M THYRO

    Time frame: 1 month

    Safety of the use of ISAR-M THYRO by means of adverse events within 1 month following thyroid surgery

Study contacts

Contact information is provided by the study sponsor or research team.

Olivia Fedunik-Brehm

CONTACT

[email protected]

+491735667761

Sabrina Koschel

CONTACT

[email protected]

+49 89 9901649975

Sponsors and collaborators

Lead sponsor

ISAR-M GmbH

Industry

Collaborators

  • CRI-The Clinical Research Institute GmbH

Registry information

Official study title

Thyroid HEmorrhage DetectOr Study

Acronym: HEDOS

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Apr 15, 2021
Registry last updated
Jul 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.